ARCHIVES

DCE Advisors approver New Grant Programs In Ovarian Cancer, Biostatistics, Biotech Transfer; Support Services Recompetitions

This article is from The Cancer Letter archive.

Vol. 18 No. 25 | June 19, 1992

Download PDF Visit The Full Archive

Related Articles

CAN-DIAL Test Generates 16,000 Calls for Cancer Information

December 13, 1974

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer

October 28, 2011

Pregnancy-Associated Breast Cancer More Likely Diagnosed At Advanced Stage

February 27, 2009

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006

Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers

April 27, 2007